Lixte Biotechnology Holdings- Warrants (01/01/2025) Common Stock

As of the most recent data (June 2026), LIXTW shows a common stock of $1.5K. That compares with $280 in the prior-year period — up 458.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIXTW's common stock is now $1.5K (was $280) — a 458.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is outperforming or lagging.

Tracking LIXTW's common stock over time shows whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5K That compares with $280 in the prior-year period — up 458.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Lixte Biotechnology Holdings- Warrants (01/01/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1.5K) with ownership activity and broader fundamentals.

Lixte Biotechnology Holdings- Warrants (01/01/2025)'s common stock is $1.5K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.